Article
A systematic approach to the development of a safe live attenuated Zika vaccine
6 Mar 2018
Abstract excerpt
Zika virus (ZIKV) is a flavivirus that can cause congenital disease and requires development of an effective long-term preventative strategy. A replicative ZIKV vaccine with properties similar to the yellow fever 17D (YF17D) live-attenuated vaccine (LAV) would be advantageous, as a single dose of YF17D produces lifelong immunity. However, a replicative ZIKV vaccine must also be safe from causing persistent organ...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
